v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:          
Net loss $ (3,716,105) $ (2,684,591) $ (13,141,074) $ (10,067,133)  
Income (loss) from discontinued operations     (2,776,013) 2,615,965  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation expense 104,835 92,984 189,869 277,573  
Amortization of intangible assets     10,251 140,437  
Amortization of deferred license costs     30,589 30,589  
Amortization of debt issuance costs and debt discount     611,721 476,894  
Amortization of right of use asset     866,800 613,092  
Gain on deconsolidation – SG DevCorp     (4,728,348)  
Loss on disposition of equity-based investment 320,408  
Change in fair value of equity-based investments 613,665 5,590,666  
Common stock issued for services     484,825  
Interest income on long-term note receivable     (21,884)  
Stock-based compensation     1,097,698 3,210,631  
Changes in operating assets and liabilities:          
Accounts receivable     14,513 539,157  
Contract assets     (173,775) 17,993  
Inventories     (585,632) 63,374  
Prepaid expenses and other current assets     (308,211) 310,150  
Intangible assets     (23,920) (71,761)  
Accounts payable and accrued expenses     881,548 2,060,288  
Contract liabilities     (611,934) 873,731  
Lease liability     (1,139,751) (925,815)  
Assumed liability     15,000  
Net cash used in operating activities by continuing operations     (8,322,569) (4,588,824)  
Net cash used in operating activities by discontinued operations     (1,593,347) (83,039)  
Cash flows from investing activities:          
Purchase of property, plant and equipment     (8,007) (522,715)  
Cash received from sale of equity-based investment     125,000  
Project development costs     (154,089) (110,279)  
Investment in and advances to equity affiliates      
Net cash used in investing activities by continuing operations     (37,096) (632,994)  
Net cash used in investing activities by discontinued operations     (364,352) (59,609)  
Cash flows from financing activities:          
Repurchase of common stock     (42,716)  
Repayment of short term notes payable     (5,143,298) (232,144)  
Proceeds from short-term notes payable and warrants, net of debt issuance costs     8,013,745 1,401,339  
Proceeds from long-term notes payable     706,359  
Proceeds from warrant inducement     494,213  
Prefunded warrant exercise     30  
Issuance of common stock for cash     3,590,386  
Issuance of common stock under EP Agreement     28,867  
Distribution paid to non-controlling interest     (46,417)  
Net cash provided by financing activities by continuing operations     6,983,943 1,786,421  
Net cash provided by financing activities by discontinued operations     3,576,166 3,708,175  
Net increase in cash and cash equivalents     242,745 130,130  
Cash and cash equivalents - beginning of period     14,212 582,776 $ 582,776
Cash and cash equivalents - end of period 256,957 712,906 256,957 712,906 $ 14,212
Less: cash and cash equivalents - discontinued operations (33,365) (33,365)  
Cash and cash equivalents - continuing operations 256,957 679,541 256,957 679,541  
Assets and liabilities effected in deconsolidation          
Assets held for sale     4,400,361  
Cash     567,473  
Prepaid expenses and other current assets     429,331  
Property and equipment, net     1,194,117  
Project development costs and other assets     91,490  
Goodwill     1,810,787  
Intangible assets     138,678  
Investments in equity-based investments     3,642,607  
Accounts payable and accrued expenses     1,600,294  
Contingent consideration payable     945,000  
Short-term notes payable     6,476,723  
Cashless warrant exercise     114  
Fractional common share adjustment     1  
Common stock deemed dividend - inducement 670,881  
Common stock deemed dividend – reduction in conversion price 475,713  
Conversion of short-term notes payable to common stock     802,087 700,000  
Fair value of warrants issued with debt     251,361  
Common stock issuance for accounts payable settlement     1,259,681  
Assets and liabilities acquired in business combination:          
Intangible assets     100,468  
Goodwill     1,810,787  
Accounts payable and accrued expenses     532,337  
Contingent consideration payable     $ 945,000  

Source

HTML PDF
XBRL
ZIP